Education
About Us
Working with TipRanks
Follow Us
NeuroOne Medical Technologies (NMTC)
NASDAQ:NMTC
RESEARCH TOOLSreports
Earnings Data
Report Date
May 08, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
―Last Year’s EPS
-0.14Same Quarter Last Year
Based on 0 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Feb 12, 2025
|% Change Since: -17.43%
|Next Earnings Date:May 08, 2025
Earnings Call Sentiment|Positive
The earnings call highlighted significant achievements in revenue growth and product margin improvements, driven by a successful partnership with Zimmer Biomet and strong performance of the OneRF ablation system. Despite an expected revenue decline in the second quarter and limited cash reserves, the overall outlook for fiscal year 2025 remains positive, with confidence in achieving set revenue and margin targets.Company Guidance
In the first quarter of fiscal year 2025, NeuroOne Medical Technologies Corporation achieved record product sales of $3.3 million, marking a 235% increase compared to $1 million in the same quarter of fiscal 2024. The company reported a total revenue of $6.3 million, including a $3 million license payment from its expanded partnership with Zimmer Biomet. NeuroOne's product gross margins also soared to 58.9%, a significant rise from 27% in the prior year. The company maintained its guidance for fiscal year 2025, projecting product revenue between $8 million and $10 million, reflecting an increase of 132% to 190% over fiscal 2024, and product gross margins between 47% and 51%. With continued product development and strategic partnerships, NeuroOne is poised for substantial growth in fiscal year 2025.Record-Breaking Revenue and Growth
NeuroOne achieved record product sales of $3.3 million, a 235% increase from $1 million in the first quarter of fiscal 2024. Total revenue for the first quarter was $6.3 million, also a record for the company.
Improved Product Gross Margins
Record product gross margins increased to 58.9% in the first quarter, nearly double from 27% in the first quarter of fiscal 2024.
Partnership with Zimmer Biomet
Expanded partnership with Zimmer Biomet, including exclusive distribution rights for the OneRF ablation system, leading to a $3 million upfront license payment.
Successful OneRF Ablation Procedures
In all but one of the OneRF ablation procedures performed to date, patients are seizure-free, with one patient being seizure-free for over nine months.
Strong Financial Position
Reported net income of $1.8 million compared to a net loss of $3.3 million in the first quarter of fiscal 2024. Operating expenses decreased by 12%.
Regained NASDAQ Compliance
Company regained compliance with NASDAQ's share price listing standards.
---
NMTC Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
NMTC Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Feb 12, 2025 | $1.09 | $1.12 | +2.75% |
| Dec 17, 2024 | $0.76 | $0.79 | +3.95% |
| Aug 14, 2024 | $0.74 | $0.73 | -1.35% |
| May 14, 2024 | $1.14 | $1.06 | -7.02% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does NeuroOne Medical Technologies (NMTC) report earnings?
NeuroOne Medical Technologies (NMTC) is schdueled to report earning on May 08, 2025, TBA Not Confirmed.
What is NeuroOne Medical Technologies (NMTC) earnings time?
NeuroOne Medical Technologies (NMTC) earnings time is at May 08, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is NMTC EPS forecast?
Currently, no data Available
---